Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarks & Spencer Regulatory News (MKS)

Share Price Information for Marks & Spencer (MKS)

Share Price is delayed by 15 minutes
Get Live Data
373.30    -1.60 (-0.43%)
Bid:
375.90
Ask:
376.30
Spread: 0.40 (0.106%)
Market Cap: £7.67b
MKS Live PriceLast checked at - London Stock Exchange

Intraday Marks & Spencer Share Chart

Marks and Spencer Chairmanship

14 Oct 2025 10:00

RNS Number : 2905D
Marks and Spencer Group PLC
14 October 2025
 

MARKS AND SPENCER GROUP PLC

(the 'Company')

MARKS AND SPENCER CHAIRMANSHIP

After extensive consultation with shareholders, executives, and advisers the Committee of Non-Executive Directors, led by the Senior Independent Director Fiona Dawson CBE, has decided to extend Archie Norman's tenure as Chairman for the next phase of the "reshaping of M&S" growth strategy. Archie started as Chairman in 2017 and therefore will reach the "comply or explain" nine-year point in eleven months' time. The Board is unanimous in its conviction that his continuation as Chairman is in the best interests of the Company and there is widespread support for this view across the shareholder base. M&S is a rapidly changing business with a recently strengthened executive team but there is a long way to go in delivering the Reshaping for Growth strategy and the Company will benefit from the continued strong leadership and stability Archie's Chairmanship will bring.The extension of his term will, in principle, last for three years from September 2026 but will be subject to a comprehensive annual review by a committee of independent directors and no major change of circumstances. The appointment will be put to annual shareholder approval at the AGM in the normal way. 

 

Fiona Dawson commented, "Archie has been an exceptional Chair, steering an effective, engaged Board and putting in place a highly capable leadership team under Stuart Machin which is transforming M&S and building a stronger, better business. There remains much to do, and Archie's deep knowledge of the business, drive and unique experience will be invaluable as we move to the next phase of the Reshaping for Growth plan."

 

-Ends-

 

For more information, please call:

Corporate Press Office: +44 (0) 20 8718 1919

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUSSWRVSURARA
Date   Source Headline
30th Aug 202410:37 amRNSDirector/PDMR Shareholding
29th Aug 20249:00 amRNSDirector/PDMR Shareholding
20th Aug 202411:05 amRNSDirector/PDMR Shareholding
8th Aug 202411:30 amRNSConfirmation of CFO appointment date
1st Aug 20249:00 amRNSTotal Voting Rights
31st Jul 20249:00 amRNSDirector/PDMR Shareholding
8th Jul 20242:37 pmRNSDirector/PDMR Shareholding
3rd Jul 20244:45 pmRNSDirectorate Change
3rd Jul 20244:11 pmRNSDirector/PDMR Shareholding
2nd Jul 20241:30 pmRNSResult of AGM
1st Jul 20249:00 amRNSBlock listing Interim Review
1st Jul 20249:00 amRNSTotal Voting Rights
28th Jun 20245:55 pmRNSDirector/PDMR Shareholding
27th Jun 20244:51 pmRNSHolding(s) in Company
25th Jun 202411:26 amRNSDirector Declaration
3rd Jun 202410:00 amRNSAnnual Financial Report
3rd Jun 20249:00 amRNSTotal Voting Rights
30th May 202412:41 pmRNSDirector/PDMR Shareholding
29th May 20244:01 pmRNSCFO announcement
29th May 20242:07 pmRNSDirector/PDMR Shareholding
28th May 20242:04 pmRNSAndrew Fisher to stand down from the Board
22nd May 20247:00 amRNSFinal Results
1st May 20249:00 amRNSTotal Voting Rights
30th Apr 20241:13 pmRNSDirector/PDMR Shareholding
2nd Apr 20249:00 amRNSTotal Voting Rights
28th Mar 20245:23 pmRNSHolding(s) in Company
28th Mar 20243:07 pmRNSDirector/PDMR Shareholding
26th Mar 20243:07 pmRNSDirector/PDMR Shareholding
7th Mar 20243:16 pmRNSHolding(s) in Company
7th Mar 20248:40 amRNSKatie Bickerstaffe - Planned Leadership Evolution
4th Mar 20243:11 pmRNSDirector/PDMR Shareholding
1st Mar 20249:00 amRNSTotal Voting Rights
28th Feb 20241:43 pmRNSDirector/PDMR Shareholding
16th Feb 20249:00 amRNSDirector Declaration
1st Feb 20249:00 amRNSTotal Voting Rights
30th Jan 20242:53 pmRNSDirector/PDMR Shareholding
15th Jan 20244:00 pmRNSDirector/PDMR Shareholding
15th Jan 20242:36 pmRNSHolding(s) in Company
11th Jan 20247:00 amRNSChristmas 2023/2024 Trading
10th Jan 20243:28 pmRNSChange To Board Committee Membership
5th Jan 20244:23 pmRNSHolding(s) in Company
2nd Jan 20249:00 amRNSBlock listing Interim Review
2nd Jan 20249:00 amRNSTotal Voting Rights
28th Dec 202311:40 amRNSDirector/PDMR Shareholding
20th Dec 202311:36 amRNSHolding(s) in Company
19th Dec 202310:30 amRNSDirector/PDMR Shareholding
14th Dec 20237:00 amRNSAdditional Listing
12th Dec 20239:13 amRNSDirector/PDMR Shareholding
1st Dec 20239:00 amRNSTotal Voting Rights
28th Nov 20232:55 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.